The Growing Femtech Longevity Market: Opportunities in Menopause and Reproductive Health for Investors

Longevity Investors
Jul 10
6 min read

Updated: Jul 11

The Femtech market, a rapidly expanding segment within healthcare and wellness, is revolutionizing how women's health needs are addressed through technology. Coined in 2016, "Femtech" encompasses a broad range of digital platforms, wearables, and personalized solutions catering to various aspects of women's health, including reproductive health, menstrual care, fertility, pregnancy, menopause, mental health, and general well-being [4, 7]. For longevity investors, this sector presents a significant and often overlooked opportunity, particularly within the menopause and reproductive health sub-sectors, which are crucial for extending women's healthy lifespans.

Market Growth and Drivers

The global Femtech market is experiencing substantial growth, with projections indicating a significant increase in market size over the next decade. In 2024, the market was valued at approximately $55.86 billion and is anticipated to reach around $130.80 billion by 2034, demonstrating an impressive Compound Annual Growth Rate (CAGR) of 8.88% from 2025 to 2034 [3]. Other estimates project the market to hit around $179.82 billion by 2034, with a CAGR of 16.38% from 2024 to 2034 [4].

Picture 1: Predicted FemTech Market Growth [4]

The longevity and mental health Femtech market specifically was valued at $1,605.7 million in 2024 and is estimated to grow at a CAGR of 16.1% from 2024 to 2030, reaching $3,914.2 million [2]. North America currently holds the largest revenue share in the overall Femtech market, with 38.64% in 2024 [3], and also leads in the number of Femtech Longevity companies [16].

Picture2: Geographical Concentration of FemTech Market Share [4]

Several key drivers are fueling this growth:

Increased Awareness and De-stigmatization: There's a growing societal openness around women's health issues, historically considered taboo. This cultural shift, supported by media campaigns and advocacy, is leading to greater demand for customized, data-driven Femtech products [4].
Technological Advancements: The proliferation of smartphones, increased digital literacy, and advancements in wearable devices and mobile applications are making health tracking and personalized solutions more accessible [3, 4].
Rising Investment and Startups: Increased funding and a growing number of startups offering novel Femtech solutions are propelling market expansion [3].
COVID-19 Pandemic Acceleration: The pandemic significantly accelerated the adoption of digital healthcare, highlighting the importance of accessible and user-friendly health tech solutions, including Femtech apps and telemedicine [1, 4].
Data-Driven Solutions: Modern Femtech companies are accumulating vast datasets, enabling the development of more targeted and effective solutions based on real-world evidence, moving towards precision medicine [13].
Artificial Intelligence (AI) Integration: AI is poised to transform women's healthcare by filling knowledge gaps, providing personalized recommendations, and scaling care delivery, especially given the historical lack of data in women's health research [13].

Focus on Menopause and Reproductive Health

Menopause Care: The menopause market alone is projected to impact 1.2 billion women and reach a value of $600 billion by 2030 [5]. Despite this immense opportunity, only about 7% of Femtech startups specifically focus on menopause, indicating a significant untapped market [5]. Digital resources and mobile health apps for menopause are gaining popularity, empowering women with knowledge and tools to manage symptoms and combat epistemic injustice often experienced in healthcare settings [1]. There is a strong need for holistic solutions that address the wide range of menopause symptoms within a single product offering [5].

Reproductive Health: This sub-sector, including fertility tracking, pregnancy care, and contraception, has historically received considerable investment and continues to be a major part of the Femtech landscape [4, 16]. It accounts for 17% of the total Femtech market by the number of companies and is among the top three subsectors by total funding [16].

Investment Trends and Challenges

While the Femtech market is booming, investment trends show a nuanced picture. Total funding to the Femtech sector reached approximately $16 billion by July 2022, a 15% increase from December 2021 [16]. Venture capital investments for Femtech companies quadrupled from $600 million in 2015 to nearly $2.4 billion in 2021 [16]. In 2024, Femtech secured $2.2 billion in funding [14].

However, Femtech still faces challenges in securing capital compared to the broader digital health market. While partnerships have risen significantly, capital deployment has grown at a slower rate compared to overall digital health investments [14]. A significant barrier is that only around 1-5% of VC funding goes to female founders or all-female teams [16]. There's also a struggle for early-stage Femtech ventures to raise Series A rounds, highlighting a funding gap for "middle" companies [14].

Despite these challenges, the market is maturing beyond early misconceptions, with investors increasingly recognizing that women's health is a vast ecosystem of interconnected opportunities, not a niche [13, 14]. The shift is moving from pure direct-to-consumer (DTC) models towards integrated partnerships with employers, insurers, and health systems [14].

Top-Funded Startups in Menopause and Reproductive Health

Several companies are making significant strides in the menopause and reproductive health longevity space:

Menopause-Focused Startups:

Vira Health (Stella): A UK-based healthtech company aiming to improve life expectancy for women going through menopause. Their core product, Stella, is a digital clinic providing personalized treatment and support for perimenopause and menopause, utilizing 90 clinical data points for hyper-personalized care. Vira Health has raised £10.81M in total funding, including a Series A investment of £8.9 million in March 2022 [6, 7, 11].
Elektra Health: Launched in 2021, Elektra Health focuses on improving menopause care with customized programs to help women manage symptoms like hot flashes and sleep changes [6, 8].
Alloy Women's Health: A US-based telehealth startup founded in 2021, offering menopause treatment [6].
Caria: An AI-powered app that provides personalized care to premenopausal and menopausal women [6, 8].
Joylux: A menopause-focused startup that uses technology-driven solutions, including wellness devices like vSculpt and vFit Gold, to address common health issues women face as they age. Joylux has raised $21.8 million [6, 8, 10].
sanoLiving: Combines technology with expert clinicians and educational content for advanced menopause support in Canada [9].
Embr Labs: A Boston-based technology startup with patented wearable technology designed to help manage hot flashes, sleep issues, stress, and thermal discomfort through personal temperature control [9, 10].
FemGevity's: Offers menopause symptom relief and healthcare solutions via telemedicine, aiming to enhance access to menopause and longevity medical solutions [9].

Reproductive Health-Focused Startups (with longevity implications):

Maven Clinic: A leading B2B digital healthcare clinic specializing in conception, pregnancy, and postpartum care. It offers services from on-demand video appointments to support for IVF and egg freezing. Maven Clinic has raised $292.1 million [6, 8, 10].
Kindbody: A healthtech company offering comprehensive fertility services and treatments, including egg and embryo freezing, donor support, and IVF. Kindbody has raised $306.3 million [6, 8, 10].
Carrot Fertility: Provides comprehensive fertility navigation, financing, and mental health support as an inclusive employer benefit. Carrot Fertility has raised $114.2 million [6, 8, 10].
Flo Health: An AI-powered women's health platform for period and ovulation tracking, offering personalized daily health insights and a secure community. Flo Health has raised £214.4M in funding [8, 11, 12].
Elvie: A healthtech company developing technology for women's intimate health issues, including an electric breast pump and a pelvic floor exercise device (Elvie Trainer). Elvie has raised $204.2 million [6, 10].
Hertility Health: Redefining reproductive healthcare with at-home hormone and fertility testing, building a large global dataset on female reproductive health to provide personalized insights and treatment. Hertility has secured £6M in total funding [7, 11].
Bloomlife: Focuses on improving maternal care by combining connected devices with data analytics to provide remote prenatal care and predict pregnancy complications [6, 8, 10, 12].
Allara Health: A telehealth startup focused on treating women with polycystic ovarian syndrome (PCOS), offering a whole-body, preventative approach [6, 7, 8, 10].
Natural Cycles: Offers a non-hormonal, app-based contraception method, which is FDA-cleared [6, 10].
DotLab: Revolutionizing endometriosis detection with a blood test that measures biomarkers associated with all stages of the condition [6, 10].
Ava: A sensor bracelet that measures physiological parameters to predict a woman's fertile window and ovulation with high accuracy [6, 10, 12].

Picture3: Reproductive Health-Focused Startups by total raised

Conclusion

The Femtech longevity market, particularly within menopause and reproductive health, represents a compelling investment opportunity. Driven by increasing awareness, technological innovation, and a growing understanding of women's unique health needs across the lifespan, this sector is poised for substantial growth. While challenges in funding remain, the maturation of the market, the shift towards integrated care models, and the immense potential for data-driven and AI-powered solutions make Femtech a vital pillar of the future digital healthcare ecosystem. Investors who recognize and capitalize on this evolving landscape stand to achieve significant returns while contributing to improved health outcomes for women globally.

Works cited

Menopause apps: Personal health tracking, empowerment and epistemic injustice - PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC12034958/
Longevity & Mental Health - Femtech market - Grand View Research: https://www.grandviewresearch.com/horizon/statistics/femtech-market-report/application/longevity-mental-health/global
Femtech Market Size to Hit Around USD 130.80 Billion by 2034 - Precedence Research: https://www.precedenceresearch.com/femtech-market
FemTech Market Size | Companies - Nova One Advisor: https://www.novaoneadvisor.com/report/femtech-market
Menopause: The $600 billion opportunity in femtech - PreScouter: https://www.prescouter.com/inquiry/untapped-menopause-market-opportunity/
20 Impressive FemTech Companies & Startups (2024) - Exploding Topics: https://explodingtopics.com/blog/femtech-startups
6 femtech startups to watch in 2025 - INNOVATION Magazine: https://innovation-mag.com/article/femtech-startups-2025/
Femtech World Menopause Innovation shortlist revealed: https://www.femtechworld.co.uk/femtech-world-awards/femtech-world-menopause-innovation-shortlist-revealed/
69 Best Femtech Startups to Watch in 2025 - Seedtable: https://www.seedtable.com/best-femtech-startups
The Femtech Startup Boom: 10 Companies to Follow: https://betaboom.com/femtech-startup-boom-top-companies/
The UK's fastest growing FemTech companies - Blog - The Data City: https://thedatacity.com/blog/the-uks-fastest-growing-femtech-companies/
5 Femtech Companies Improving Women-Centric Healthcare - Plug and Play: https://www.plugandplaytechcenter.com/insights/femtech-companies-improving-women-centric-healthcare
NY Tech Week 2025: The Future of Femtech | Fenwick: https://www.fenwick.com/insights/publications/ny-tech-week-2025-the-future-of-femtech
Galen Growth FemTech 2.0 Report: Elevating Women's Health from Niche to Necessity: https://medika.life/galen-growth-femtech-2-0-report-elevating-womens-health-from-niche-to-necessity/
Mind the Gap: Why FemTech Needs More Investment Now - [Session VivaTech] - Theme: Health & Longevity: https://vivatechnology.com/sessions/session/d1ad94a9-250b-f011-aaa7-6045bd9d3cdc
FemTech Industry Landscape Q2 2022 - Deep Knowledge Group: https://analytics.dkv.global/FemTech/Teaser-Q2-2022.pdf